Individualised treatment effects of corticosteroids in IgA nephropathy (Hölscher DL, Schmitz NEJ, Niggemeier L, Pilva P, Strauch M, Tesar V, Barratt J, Roberts ISD, Coppo R, Barisoni L, Yanagita M, Alabalik U, Rule AD, Jagtap JM, Abreu ES, Seikrit C, von Stillfried S, Taal MW, Kalra PA, Floege J, Kramann R, Boor P, Bülow RD, Russo ML, Troyanov S, Cook HT, Roberts ISD, Tesar V, Maixnerova D, Lundberg S, Gesualdo L, Emma F, Diomedi F, Beltrame G, Rollino C, Amore A, Camilla R, Peruzzi L, Praga M, Feriozzi S, Polci R, Segoloni G, Colla L, Pani A, Piras D, Angioi A, Cancarini G, Ravera S, Durlik M, Moggia E, Ballarin J, Di Giulio S, Pugliese F, Serriello I, Caliskan Y, Sever M, Kilicaslan I, Locatelli F, Del Vecchio L, Wetzels JFM, Peters H, Berg U, Carvalho F, da Costa Ferreira AC, Maggio M, Wiecek A, Ots-Rosenberg M, Magistroni R, Topaloglu R, Bilginer Y, D’Amico M, Stangou M, Giacchino F, Goumenos D, Kalliakmani P, Papasotiriou M, Galesic K, Geddes C, Siamopoulos K, Balafa O, Galliani M, Stratta P, Quaglia M, Bergia R, Cravero R, Salvadori M, Cirami L, Fellstrom B, Kloster Smerud H, Ferrario F, Stellato T, Egido J, Martin C, Floege J, Eitner F, Lupo A, Bernich P, Menè P, Morosetti M, van Kooten C) Ebiomedicine August 2026;130 SCOPUS ID: 2-s2.0-105044431641 08/01/2026